UIMZ:XETRA:XETRA-UBS(Lux)Fund Solutions – Factor MSCI EMU Prime Value UCITS ETF(EUR)A-dis (EUR)

ETF | Others |

Last Closing

USD 19.672

Change

+0.21 (+1.06)%

Market Cap

N/A

Volume

1.03K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.61 (+1.40%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.75 (-0.84%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.22 (+0.97%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.07 (+0.54%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.03 (+0.60%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.16 (+0.72%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.16 (-1.42%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

+1.58 (+2.81%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

N/A

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.20 (+0.17%)

USD 12.26B

ETFs Containing UIMZ:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.33% 81% B- 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.33% 83% B 76% C+
Trailing 12 Months  
Capital Gain -0.08% 52% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.08% 55% F 54% F
Trailing 5 Years  
Capital Gain 55.36% 61% D- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 55.36% 62% D 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 7.30% 54% F 54% F
Dividend Return 9.56% 62% D 61% D-
Total Return 2.26% 93% A 75% C
Risk Return Profile  
Volatility (Standard Deviation) 12.00% 52% F 61% D-
Risk Adjusted Return 79.67% 69% C- 73% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike